Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-x4r87 Total loading time: 0 Render date: 2024-04-27T02:43:02.429Z Has data issue: false hasContentIssue false

Chapter 10 - The Use of ECT in the Treatment of Schizophrenia

Published online by Cambridge University Press:  27 June 2019

By
Richard Braithwaite
Edited by
I. Nicol Ferrier  and
Jonathan Waite
I. Nicol Ferrier
Affiliation:
University of Newcastle upon Tyne
Jonathan Waite
Affiliation:
University of Nottingham
Get access

Summary

Electroconvulsive therapy is widely used in the treatment of schizophrenia. Historically, in contrast to affective disorders, there has been relatively limited high-quality evidence to support its use for this indication. Consequently, the last edition of The ECT Handbook (Waite & Easton, 2013) sanctioned its use only as a short-term intervention, in clozapine-resistant illness. Since that time, there has been renewed interest in the topic amongst researchers and several recent publications have helped guide this updated chapter.

Type
Chapter
Information
The ECT Handbook , pp. 74 - 84
Publisher: Cambridge University Press
Print publication year: 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Baker, A., Bird, G., Lavin, N. & Thorpe, J. (1960) ECT in schizophrenia. Journal of Mental Science, 106, 1506–11.Google Scholar
Barnes, T. R. (2011) Schizophrenia Consensus Group of British Association for Psychopharmacology: evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology, 25, 567–620.Google Scholar
Brenner, H. D., Dencker, S. J., Goldstein, M. J., et al. (1990) Defining treatment refractoriness in schizophrenia. Schizophrenia Bulletin, 16, 551–61.Google Scholar
Buley, N., Copland, E. & Hodge, S. (2017) ECT minimum dataset 2016–2017. Electroconvulsive Therapy Accreditation Service, Royal College of Psychiatrists.Google Scholar
Caldwell, C. B. & Gottesman, I. I. (1992) Schizophrenia: a high-risk factor for suicide: clues to risk reduction. Suicide & Life-Threatening Behavior, 22, 479–93.Google Scholar
Cerletti, U. & Bini, L. (1938) Un nuevo metodo di shocktherapie “L’elettro-shock”. Bollettino dell’Accademia medica di Roma, 64, 136–8.Google Scholar
Chanpattana, W., Chakrabhand, M. L., Sackeim, H. A., et al. (1999a) Continuation ECT in treatment resistant schizophrenia: a controlled study. Journal of ECT, 15, 178–92.CrossRefGoogle ScholarPubMed
Chanpattana, W., Chakrabhand, M. L., Kitaroonchai, W., Choovanichvong, S. & Prasertsuk, Y. (1999b) Effects of twice- versus thrice-weekly electroconvulsive therapy in schizophrenia. Journal of the Medical Association of Thailand, 82, 477–83.Google Scholar
Chanpattana, W. & Sackeim, H. A. (2010) Electroconvulsive therapy in treatment-resistant schizophrenia: prediction of response and the nature of symptomatic improvement. Journal of ECT, 26, 289–98.Google Scholar
Fink, M. (1979) Convulsive therapy: theory and practice. Raven Press.Google Scholar
Fink, M. (1999) Electroshock: healing mental illness. Oxford University Press.Google Scholar
Gaupp, R. (1926) Die Frage der kombinierten Psychosen. Archiv für Psychiatrie und Nervenkrankheiten, 76, 73–80.CrossRefGoogle Scholar
Hechst, B. (1931) Zur Histopathologie der Schizophrenie mit besonderer Berücksichtigung der Ausbreitung des Prozesses. Zeitschrift für die gesamte Neurologie und Psychiatrie, 134, 163–7.CrossRefGoogle Scholar
Janakiramiah, N., Channabasavanna, S. M. & Narasimha-Murthy, N. S. (1982) ECT/chlorpromazine combination versus chlorpromazine alone in acutely ill schizophrenic patients. Acta Psychiatrica Scandinavica, 66, 464–70.Google Scholar
Kho, K. H., Blansjaar, B. A., de Vries, S., Babuskova, D., Zwinderman, A. H. & Linszen, D. H. (2004) Electroconvulsive therapy for the treatment of clozapine non-responders suffering from schizophrenia: an open label study. European Archives of Psychiatry & Clinical Neuroscience, 254, 372–9.Google Scholar
Lally, J., Tully, J., Robertson, D., Stubbs, B., Gaughran, F. & MacCabe, J. H. (2016) Augmentation of clozapine with electroconvulsive therapy in treatment resistant schizophrenia: a systematic review and meta-analysis. Schizophrenia Research, 171, 215–24.Google Scholar
Leiknes, K. A., Jarosh-von-Schweder, L. & Høie, B. (2012) Contemporary use and practice of electroconvulsive therapy worldwide. Brain & Behavior, 2, 283–302.CrossRefGoogle ScholarPubMed
Lévy-Rueff, M., Jurgens, A., Lôo, H., Olié, J. P. & Amado, I. (2008) Maintenance electroconvulsive therapy and treatment of refractory schizophrenia. Encephale, 34, 526–33.Google Scholar
Masoudzadeh, A. & Khalilian, A. R. (2007) Comparative study of clozapine, electroshock and the combination of ECT with clozapine in treatment-resistant schizophrenic patients. Pakistan Journal of Biological Science, 10, 4287–90.Google Scholar
Meduna, L. J. (1932) Klinische und anatomische Beiträge zur Frage der genuinen Epilepsie. Deutsche Zeitschrift für Nervenheilkunde, 129, 14–42.CrossRefGoogle Scholar
Meduna, L. J. (1934) Űber experimentelle Campherepilepsie. Archiv für Psychiatrie, 102, 333–9.Google Scholar
Meduna, L. J. (1935) Versuche über die biologische Beeinflussung des Ablaufes der Schizophrenie: Campher und Cardiazol. Zeitschrift für die gesamte Neurologie und Psychiatrie, 152, 235–62.Google Scholar
Meduna, L. J. (1937) Die Konvulsionstherapie der Schizophrenie. Carl Marhold.Google Scholar
Melzer-Ribeiro, D. L., Rigonatti, S. P., Kayo, M., et al. (2017) Efficacy of electroconvulsive therapy augmentation for partial response to clozapine: a pilot randomized ECT – sham controlled trial. Archives of Clinical Psychiatry, 44, 45–50.Google Scholar
Murray, R. M., Quattrone, D., Natesan, S., et al. (2016) Should psychiatrists be more cautious about long-term prophylactic use of antipsychotics? British Journal of Psychiatry, 209, 361–5.Google Scholar
Naidoo, N. (1956) The effects of reserpine (serpasil) on the chronic disturbed schizophrenic: a comparative study of rauwolfia alkaloids and electroconvulsive therapy. Journal of Nervous and Mental Disease, 123, 1–13.Google Scholar
National Institute for Health and Care Excellence (2009) Guidance on the use of electroconvulsive therapy (Technology Appraisal TA59). NICE.Google Scholar
National Institute for Health and Care Excellence (2014) Psychosis and schizophrenia in adults: prevention and management (Clinical Guideline CG178). NICE.Google Scholar
Nielsen, J., Dahm, M., Lublin, H. & Taylor, D. (2010) Psychiatrists’ attitude towards and knowledge of clozapine treatment. Journal of Psychopharmacology, 24, 965–71.Google Scholar
Petrides, G., Malur, C., Braga, R. J., et al. (2015) Electroconvulsive therapy augmentation in clozapine-resistant schizophrenia: a prospective, randomised study. American Journal of Psychiatry, 172, 52–8.Google Scholar
Phutane, V. H., Thirthalli, J., Muralidharan, K., Naveen Kumar, C., Keshav Kumar, J. & Gangadhar, B. N. (2013) Double-blind randomized controlled study showing symptomatic and cognitive superiority of bifrontal over bitemporal electrode placement during electroconvulsive therapy for schizophrenia. Brain Stimulation, 6, 210–17.Google Scholar
Pompili, M., Lester, D., Dominici, G., et al. (2013) Indications for electroconvulsive treatment in schizophrenia: a systematic review. Schizophrenia Research, 142, 1–9.CrossRefGoogle Scholar
Pullar Strecker, H. (1937) Book review: Convulsion therapy in schizophrenia [Die Konvulsionstherapie der Schizophrenie] by Ladislaus von Meduna. British Journal of Psychiatry, 83, 727–8.Google Scholar
Samara, M. T., Dold, M., Gianatsi, M., et al. (2016) Efficacy, acceptability and tolerability of antipsychotics in treatment-resistant schizophrenia: a network meta-analysis. JAMA Psychiatry, 73, 199–210.CrossRefGoogle ScholarPubMed
Shiloh, R., Zemishlany, Z., Aizenberg, D., et al. (1997) Sulpiride augmentation in people with schizophrenia partially responsive to clozapine: a double-blind, placebo-controlled study. British Journal of Psychiatry, 171, 569–73.CrossRefGoogle ScholarPubMed
Shorter, E. & Healy, D. (2007 ) Shock therapy: a history of electroconvulsive treatment in mental illness. University of Toronto Press.Google Scholar
Small, J. G., Milstein, V., Klapper, M., Kellams, J. J. & Small, I. F. (1982) ECT combined with neuroleptics in the treatment of schizophrenia. Psychopharmacology Bulletin, 18, 34–5.Google Scholar
Sommer, I. E., Begemann, M. J. H., Temmerman, A. & Leucht, S. (2012) Pharmacological augmentation strategies for schizophrenia patients with insufficient response to clozapine: a quantitative literature review. Schizophrenia Bulletin, 38, 1003–11.Google Scholar
Tharyan, P. & Adams, C. E. (2005) Electroconvulsive therapy for schizophrenia. Cochrane Database of Systematic Reviews.CrossRefGoogle Scholar
Vuksan Ćusa, B., Klepac, N., Jakšić, N., et al. (2018) The effects of electroconvulsive therapy augmentation of antipsychotic treatment on cognitive functions in patients with treatment-resistant schizophrenia. Journal of ECT, 34, 31–4.Google Scholar
Waite, J. & Easton, A. (eds.) (2013) The ECT Handbook (3rd edn) (Council Report CR128), pp140–57. Royal College of Psychiatrists.Google Scholar
Wang, G., Zheng, W., Li, X. B., et al. (2018) ECT augmentation of clozapine for clozapine-resistant schizophrenia: a meta-analysis of randomized controlled trials. Journal of Psychiatric Research, 105, 23–32.CrossRefGoogle ScholarPubMed
Wu, D., She, C. W., She, C. W., et al. (1989) Using BPRS and serial numbers and picture recall to test the effectiveness of ECT and chlorpromazine versus chlorpromazine alone in the treatment of schizophrenia: 40 cases, single blind observations. Chinese Journal of Nervous and Mental Disorders, 15, 26–8.Google Scholar
Zheng, W., Cao, X. L., Ungvari, G. S., et al. (2016) Electroconvulsive therapy added to non-clozapine antipsychotic medication for treatment resistant schizophrenia: meta-analysis of randomized controlled trials. PLoS ONE, 11, e0156510.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×